Biotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Immunology Division, Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt.
Sci Rep. 2023 Jun 30;13(1):10617. doi: 10.1038/s41598-023-36929-0.
Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fact that melatonin is quickly transported through the mucosa, its sensitivity to be oxidized creates a difficulty in achieving the required dose. Additionally, due to its variable absorption and poor oral bioavailability necessitates the development of alternative delivery methods. The study aimed to synthesize melatonin loaded chitosan/lecithin (Mel-C/L) nanoparticles to be assessed in the treatment of streptozotocin (STZ)-induced diabetes in rats. The antioxidant, anti-inflammatory, and cytotoxicity properties of nanoparticles were estimated to determine the safety of manufactured nanoparticles for in vivo studies. In addition, Mel-C/L nanoparticles were administered to rats for eight weeks after inducing hyperglycemia. The therapeutic effect of Mel-C/L nanoparticles was assessed in all experimental groups by detecting insulin and blood glucose levels; observing improvements in liver and kidney functions as well as histological and immunohistochemical evaluation of rats' pancreatic sections. The results proved that Mel-C/L nanoparticles showed remarkable anti-inflammatory, anti-coagulant, and anti-oxidant effects, in addition to its efficiency in reducing blood glucose levels of STZ-induced diabetic rats and great ability to promote the regeneration of pancreatic beta (β)-cells. Furthermore, Mel-C/L nanoparticles elevated the insulin level; and decreased the elevated levels of urea, creatinine and cholesterol. In conclusion, nanoparticles application decreased the administrated melatonin dose that in turn can diminish the side effects of free melatonin administration.
纳米技术被用于克服当今市售药物中阻碍治疗的固有缺陷,如药物溶解度有限和药物迅速释放到血液中。在人体和动物研究中,褪黑素被证明可以调节血糖水平。尽管褪黑素可以迅速穿过黏膜,但它很容易被氧化,这给达到所需剂量带来了困难。此外,由于其吸收可变和口服生物利用度差,需要开发替代的给药方法。本研究旨在合成负载褪黑素的壳聚糖/卵磷脂(Mel-C/L)纳米粒,并在链脲佐菌素(STZ)诱导的糖尿病大鼠模型中进行评估。评估纳米粒的抗氧化、抗炎和细胞毒性特性,以确定所制备的纳米粒用于体内研究的安全性。此外,在诱导高血糖后,将 Mel-C/L 纳米粒施用于大鼠 8 周。通过检测胰岛素和血糖水平,观察肝脏和肾脏功能的改善,以及对大鼠胰腺切片的组织学和免疫组织化学评估,评估 Mel-C/L 纳米粒在所有实验组中的治疗效果。结果表明,Mel-C/L 纳米粒具有显著的抗炎、抗凝和抗氧化作用,除了能有效降低 STZ 诱导的糖尿病大鼠的血糖水平外,还能促进胰腺β(β)-细胞的再生。此外,Mel-C/L 纳米粒还能提高胰岛素水平,降低尿素、肌酐和胆固醇的升高水平。综上所述,纳米粒的应用减少了褪黑素的给药剂量,从而减少了游离褪黑素给药的副作用。